The journey of a drug from concept to market is paved with the precise synthesis of specialized chemical intermediates. 4-Methylphenylsulfonylurea, bearing the CAS number 1694-06-0, is one such compound that holds significant importance in the pharmaceutical sector, particularly in the development of antidiabetic medications.

This white crystalline powder, typically with an assay of 99.0%min, is a key intermediate in the synthesis of oral hypoglycemic agents. These pharmaceuticals are vital for managing type 2 diabetes mellitus by stimulating insulin secretion. The consistent quality and high purity of 4-Methylphenylsulfonylurea are therefore critical for the efficacy and safety of the final drug product.

For research and development departments within pharmaceutical companies, securing a reliable supply of this intermediate is paramount. Procurement managers often seek out experienced manufacturers and suppliers who can guarantee consistent product quality and offer competitive pricing. Sourcing from reputable chemical suppliers in China can be a strategic advantage, providing access to a robust manufacturing base and efficient logistics.

Beyond its primary role in antidiabetic drug synthesis, 4-Methylphenylsulfonylurea also finds application in broader organic synthesis, serving as a valuable building block for creating complex molecules with potential therapeutic properties. Its well-defined chemical characteristics, including a melting point of 196-198°C, make it a predictable component in synthesis pathways.

When evaluating suppliers, it is important to request detailed product specifications, Certificates of Analysis (CoA), and Safety Data Sheets (SDS). These documents confirm the purity and quality of the 4-Methylphenylsulfonylurea, ensuring it meets the stringent requirements of pharmaceutical research and manufacturing. Understanding the compound's properties and applications helps R&D teams make informed decisions about its integration into their synthesis strategies.

In conclusion, 4-Methylphenylsulfonylurea (CAS 1694-06-0) is an indispensable intermediate for drug development. By partnering with reliable manufacturers and suppliers, pharmaceutical companies can ensure they have a consistent and high-quality supply of this critical building block, accelerating their efforts in bringing new therapies to market.